Learning Objectives:

1.         Review the use of anti-PLA2R antibody for diagnosis, prognosis and informing treatment decisions in Membranous Nephropath

2.         Discuss the evidence behind current immunosuppression paradigms for membranous nephropathy

Session date: 
05/30/2024 - 4:00pm to 5:00pm CDT
Location: 
Via Zoom
5841 S. Maryland Ave
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Yonatan Peleg, MD